Re-inventing tumor targeting

Best-in-class, TSL-based tumor targeting.
Explore the science behind Thermosome’s tumor targeting
Setting a new standard for the treatment of locally advanced soft tissue sarcoma.
Explore Thermosome’s pipeline
Experienced team of biotech entrepreneurs.
Get to know Thermosome’s team

Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.

Latest news

Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001

Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board

more news

Upcoming event

BIO-Europe Spring

March 18–20, 2024, Barcelona, Spain
March 26–27, 2024, Digital Partnering

more Events